普鲁维阿托利德通过调节母细胞激活来减轻I型过敏症
Seon Young Kim1, Jeong Won Park1, Juhyun Shin1
1Department of Biomedical Sciences, College of Natural Science and Department of Health Sciences, The Graduate School of Dong-A University, Busan 49315, Republic of Korea.
Biomolecules & therapeutics
|February 27, 2026
概括
普鲁维亚托利德通过阻断关键信号通路,有效地抑制瘤细胞激活和过敏反应. 这种天然化合物显示出治疗各种过敏疾病的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 乳腺细胞在过敏反应中发挥着中心作用,特别是IgE介导的I型过敏症.
- FcεRI信号传递和细胞内 (Ca2+) 调动是巨细胞激活的关键途径.
- 波多菲勒姆·赫克桑德鲁姆 (Podophyllum hexandrum) 是一种具有潜在治疗性质的生物活性基素的来源.
研究的目的:
- 为了研究普鲁维阿托利德对巨细胞激活的抑制作用.
- 阐明普鲁瓦托利德的作用背后的机制,重点关注FcεRI依赖和Ca2+依赖的途径.
- 在过敏性炎症的临床前模型中评估普鲁瓦托利德的疗效.
主要方法:
- 实验中使用了骨髓衍生性巨细胞 (BMMC) 和RBL-2H3细胞系.
- 测试包括β-hexosaminidase释放,细胞因子表达 (TNF-α,IL-6) 和对信号蛋白的免疫阻塞.
- 用一种被动皮肤过敏反应 (PCA) 鼠标模型来评估体内效应.
主要成果:
- 普鲁维阿托利德显著抑制了脱粒和抑制了TNF-α和IL-6的释放,没有细胞毒性.
- 它证明了对FcεRI依赖的和受体独立的Ca2+依赖性巨细胞激活的有效性.
- 普鲁维阿托利德降低了关键信号分子的酸化,包括Lyn,Syk,LAT,PLCγ1,MAPK和NF-κB.
- 在体内,在PCA模型中,普鲁维阿托利德的使用降低了血管透性和巨细胞脱粒化.
结论:
- 普鲁维阿托利德通过信号通路的多节点抑制有效地抑制瘤细胞激活和过敏反应.
- 它能够准IgE介导和非IgE介导的机制,使其成为一个有前途的治疗候选者.
- 对普鲁瓦托利德的进一步研究可能会为一系列过敏症带来新的治疗方法.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
01:19Antiasthma Drugs: Leukotriene Modifiers
2.0K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.0K
01:30Hypersensitivities
7.9K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.9K
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
87
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
87
01:27Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K
01:30Drug Toxicity: Allergic Reactions
64
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
64